{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:38:04Z","timestamp":1781134684641,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40262-020-00903-0","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T04:03:16Z","timestamp":1590724996000},"page":"1589-1599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Pharmacokinetics and Glucodynamics of Ultra\u00a0Rapid Lispro (URLi) versus Humalog\u00ae (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial"],"prefix":"10.1007","volume":"59","author":[{"given":"Helle","family":"Linnebjerg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"LaBell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Anne","family":"Dellva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Coutant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"H\u00f6velmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"Plum-M\u00f6rschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Herbrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Leohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"issue":"Suppl 1","key":"903_CR1","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc13-S011","volume":"36","author":"American Diabetes Association","year":"2013","unstructured":"American Diabetes Association. Standards of medical care in diabetes \u2013 2013. Diabetes Care. 2013;36(Suppl 1):S11\u201366.","journal-title":"Diabetes Care."},{"issue":"7","key":"903_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jcjd.2019.01.004","volume":"43","author":"P Senior","year":"2019","unstructured":"Senior P, Hramiak I. Fast-acting insulin aspart and the need for new mealtime insulin analogues in adults with type 1 and type 2 diabetes: a Canadian perspective. Can J Diabetes. 2019;43(7):515\u201323.","journal-title":"Can J Diabetes."},{"issue":"4","key":"903_CR3","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1177\/193229681200600402","volume":"6","author":"L Heinemann","year":"2012","unstructured":"Heinemann L, Muchmore DB. Ultrafast-acting insulins: state of the art. J Diabetes Sci Technol. 2012;6(4):728\u201342.","journal-title":"J Diabetes Sci Technol."},{"key":"903_CR4","doi-asserted-by":"crossref","unstructured":"Heise T. Getting closer to physiologic insulin secretion. Clin Ther. 2007;29 Suppl D:S161\u20135.","DOI":"10.1016\/j.clinthera.2007.12.012"},{"issue":"2","key":"903_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1056\/NEJMra040832","volume":"352","author":"IB Hirsch","year":"2005","unstructured":"Hirsch IB. Insulin analogues. N Engl J Med. 2005;352(2):174\u201383.","journal-title":"N Engl J Med."},{"issue":"7","key":"903_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/(SICI)1096-9136(199607)13:7<625::AID-DIA134>3.0.CO;2-2","volume":"13","author":"L Heinemann","year":"1996","unstructured":"Heinemann L, Heise T, Wahl LC, Trautmann ME, Ampudia J, Starke AA, et al. Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin. Diabet Med. 1996;13(7):625\u20139.","journal-title":"Diabets Med."},{"key":"903_CR7","unstructured":"Humalog [package insert]. Indianapolis, IN: Eli Lilly and Company; 2017."},{"key":"903_CR8","unstructured":"Remodulin [package insert for US]. Research Triangle Park, NC: United Therapeutics; 2019."},{"issue":"Suppl 1","key":"903_CR9","first-page":"A253","volume":"66","author":"E Pratt","year":"2017","unstructured":"Pratt E, Leohr J, Heilmann C, Johnson J, Landschulz W. Treprostinil causes local vasodilation, is well tolerated, and results in faster absorption of insulin lispro. Diabetes. 2017;66(Suppl 1):A253.","journal-title":"Diabetes."},{"key":"903_CR10","unstructured":"Paavola CD, Cox AL, Sperry AE, Hansen RJ, Li S, Bradley SA, et al. A stable, hexameric, ultra-rapid insulin formulation containing citrate. Diabetes. 2017;66 (Suppl\u00a01):A254."},{"key":"903_CR11","doi-asserted-by":"publisher","unstructured":"Shiramoto M, Nasu R, Oura T, Imori M, Ohwaki K. Ultra-Rapid Lispro results in accelerated insulin lispro absorption and faster early insulin action in comparison to Humalog\u00ae in Japanese patients with type 1 diabetes. J Diabetes Investig. Epub 9 Dec 2019. https:\/\/doi.org\/10.1111\/jdi.13195.","DOI":"10.1111\/jdi.13195"},{"key":"903_CR12","doi-asserted-by":"crossref","unstructured":"Blevins T, Zhang Q, Frias JP, Jinnouchi H, Chang AM. Randomized double-blind clinical trial comparing Ultra rapid lispro with Lispro in a basal-bolus regimen in patients with type 2 diabetes: PRONTO-T2D. Diabetes Care. 2020; (in press).","DOI":"10.2337\/figshare.12149319.v1"},{"key":"903_CR13","doi-asserted-by":"crossref","unstructured":"Klaff LJ, Cao D, Dellva MA, Tobian J, Miura J, Dahl D, et al. Ultra rapid lispro (URLi) improves postprandial glucose (PPG) control vs. Humalog (Lispro) in T1D: PRONTO-T1D study. Diabetes. 2019;68 Suppl\u00a01:144-OR.","DOI":"10.2337\/db19-144-OR"},{"issue":"4","key":"903_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.2337\/dci17-0005","volume":"40","author":"RR Kalyani","year":"2017","unstructured":"Kalyani RR, Golden SH, Cefalu WT. Diabetes and aging: unique considerations and goals of care. Diabetes Care. 2017;40(4):440\u20133.","journal-title":"Diabetes Care."},{"key":"903_CR15","unstructured":"US Food and Drug Administration. Guidance for Industry. Guideline for the study of drugs likely to be used in the elderly. 1989. Available at: https:\/\/www.fda.gov\/media\/71114\/download. Accessed 30 Nov 2019."},{"key":"903_CR16","unstructured":"European Medicines Agency. Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus. 2012. Available at: https:\/\/www.ema.europa.eu\/documents\/scientific-guideline\/guideline-clinical-investigation-medicinal-products-treatment-prevention-diabetes-mellitus-revision_en.pdf. Accessed 2 Dec 2019."},{"key":"903_CR17","unstructured":"Chow S, Liu J. Design and analysis of bioavailability and bioequivalence studies. 3rd ed. Boca Raton, FL: Taylor and Francis Group, LLC; 2009. pp. 88\u201390."},{"issue":"2","key":"903_CR18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1172\/JCI113339","volume":"81","author":"KS Polonsky","year":"1988","unstructured":"Polonsky KS, Given BD, Van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest. 1988;81(2):442\u20138.","journal-title":"J Clin Invest."},{"issue":"12","key":"903_CR19","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2337\/diab.28.12.1095","volume":"28","author":"RA Defronzo","year":"1979","unstructured":"Defronzo RA. Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes. 1979;28(12):1095\u2013101.","journal-title":"Diabetes."},{"issue":"2","key":"903_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ecl.2013.02.010","volume":"42","author":"RR Kalyani","year":"2013","unstructured":"Kalyani RR, Egan JM. Diabetes and altered glucose metabolism with aging. Endocrinol Metab Clin North Am. 2013;42(2):333\u201347.","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"10","key":"903_CR21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.2337\/diab.31.10.851","volume":"31","author":"KL Minaker","year":"1982","unstructured":"Minaker KL, Rowe JW, Tonino R, Pallotta JA. Influence of age on clearance of insulin in man. Diabetes. 1982;31(10):851\u20135.","journal-title":"Diabetes."}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-020-00903-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-020-00903-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-020-00903-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T23:28:15Z","timestamp":1622244495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-020-00903-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["903"],"URL":"https:\/\/doi.org\/10.1007\/s40262-020-00903-0","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]},"assertion":[{"value":"29 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was funded by Eli Lilly and Company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Helle Linnebjerg, Qianyi Zhang, Elizabeth LaBell, Mary Anne Dellva, David E. Coutant, and Jennifer Leohr are employees and shareholders of Eli Lilly and Company. Ulrike H\u00f6velmann, Leona Plum-M\u00f6rschel, and Theresa Herbrand are employees of Profil.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Eli Lilly and Company provides access to all individual participant data collected during the trial, after anonymization, with the exception of pharmacokinetic or genetic data. Data are available to request 6\u00a0months after the indication studied has been approved in the United States and European Union and after primary publication acceptance, whichever is later. No expiration date of data requests is currently set once data are made available. Access is provided after a proposal has been approved by an independent review committee identified for this purpose and after receipt of a signed data sharing agreement. Data and documents, including the study protocol, statistical analysis plan, clinical study report, blank or annotated case report forms, will be provided in a secure data sharing environment. For details on submitting a request, see the instructions provided at .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Sharing"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee (Medical Council North Rhine, D\u00fcsseldorf, Germany, 2017020) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Informed Consent"}}]}}